Summary
Islet amyloid polypeptide (IAPP), a novel islet hormone candidate, has been reported to be over-expressed relative to insulin in rats following dexamethasone treatment. In order to investigate the expression of IAPP and insulin following dexamethasone treatment of rats for 12 days, we applied in situ hybridization and immunocytochemistry, allowing us to evaluate islet changes in gene expression and morphology. Tissue concentrations of IAPP and insulin were measured by radioimmunoassay. A low dose of dexamethasone (0.2 mg/kg daily) increased the islet levels of IAPP and insulin mRNA to 249±13% and 150±24% of controls, respectively (p<0.001 and p<0.01). A high dose of dexamethasone (2.0 mg/kg daily) increased the islet levels of IAPP and insulin mRNA to 490±13% and 203±9% of controls, respectively (p<0.001 and p<0.001). The pancreatic concentration of IAPP increased more than that of insulin (p<0.05). Morphometric analysis revealed that dexamethasone treatment induced both hyperplasia and hypertrophy of insulin cells. Changes in the cellular localization of IAPP and insulin mRNA were not observed. Thus, we conclude that the increased level of IAPP mRNA is due to both an increase at the cellular level as well as hyperplasia/hypertrophy of insulin cells. In contrast, the increased level of insulin mRNA appears to be due to hyperplasia/hypertrophy of insulin cells, since insulin gene expression decreased at the cellular level (p<0.001 vs controls). These observations provide further evidence that IAPP and insulin gene expression are regulated in a non-parallel fashion, which may be relevant to the pathogenesis of non-insulin-dependent diabetes mellitus
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IAPP:
-
islet amyloid polypeptide
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- ISH:
-
in situ hybridization
- SSC:
-
saline sodium citrate
- CGRP:
-
calcitonin gene related peptide
References
Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene-related peptide family as an amyloid protein fibril in the endocrine pancreas. Biochem Biophys Res Commun 140: 827–831
Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628–8632
Johnson KH, O'Brien TD, Hayden DW et al. (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic Β-cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Path 130: 1–8
Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 8628–8632
Westermark P, Johnson KH, O'Brien TD, Betsholz C (1992) Islet amyloid polypeptide — a novel controversy in diabetes research. Diabetologia 35: 297–303
Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632–635
Frontoni S, Choi SB, Banduch D, Rossetti L (1990) In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 40: 568–573
Koopmans SJ, van Mansfeld ADM, Jansz HS et al. (1991) Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 34: 218–224
Wang ZL, Bennet WM, Ghatei MA, Byfield PGH, Smith DM, Bloom SR (1993) Influence of islet amyloid polypeptide and the 8–37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42: 330–335
Dégano P, Silvestre RA, Salas M, Peiro E, Marco J (1993) Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept 43: 91–96
Bretherton-Watt D, Ghatei MA, Bloom SR et al. (1989) Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia 32: 881–883
O'Brien TD, Westermark P, Johnson KH (1991) Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes 40: 1701–1706
Pieber TR, Stein DT, Ogawa A et al. (1993) Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycaemia. Am J Physiol 265: E446-E453
Lazarus SS, Volk BW (1962) The Pancreas in Human and Experimental Diabetes, 1st edn., Grune & Stratton, New York
Swenne I (1992) Pancreatic beta-cell growth and diabetes. Diabetologia 35:193–201
Ahrén B, Sundler F (1992) Localization of calcitonin generelated peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res 289: 315–322
Mulder H, Lindh A-C, Sundler F (1993) Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat. A combined in situ hybridization and immunocytochemical study. Cell Tissue Res 274: 467–474
Leffert JD, Newgard CB, Okamoto H, Milburn JL, Luskey KL (1989) Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci USA 86: 3127–3130
Amara SG, Evans RM, Rosenfeld MG (1984) Calcitonin/calcitonin gene-related peptide transcription unit: tissue-specific expression involves selective use of alternative polyadenylation sites. Mol Cell Biol 4: 2151–2160
Lomedico P, Rosenthal N, Efstratiadis A, Gilbert W, Kolodner R, Tizard R (1979) The structure and evolution of the two nonallelic rat preproinsulin genes. Cell 18: 545–558
Morgan CR, Lazarow A (1963) Immunoassay of insulin. Two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115–126
Stridsberg M, Wilander E, öberg K, Lundqvist G, Eriksson B (1992) Islet amyloid polypeptide-producing pancreatic islet cell tumor. A clinical and biochemical characterization. Scand J Gastroenterol 27: 381–387
Philippe J, Missotten M (1990) Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells. Endocrinology 127: 1640–1645
Fernandez-Meija C, Goodman P, Davidson M (1993) Hormonal regulation of human insulin gene transcription. Diabetes 42: [Suppl 1]731
Giddings SJ, Orland MJ, Weir GC, Bonner-Weir S, Permutt MA (1985) Impaired insulin biosynthetic capacity in a rat model for non-insulin-dependent diabetes. Studies with dexamethasone. Diabetes 34: 235–240
Koranyi L, Bourey R, Turk J, Mueckler M, Permutt MA (1992) Differential expression of rat pancreatic islet betacell glucose transporter (Glut 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment. Diabetologia 35: 1125–1132
Like AA, Chick WL (1974) Pancreatic beta cell replication induced by glucocorticoids in subhuman primates. Am J Pathol 75: 329–348
Bonner-Weir S, Trent DF, Zmachinski CJ, Clore ET, Weir GC (1981) Limited B cell regeneration in a B cell deficient rat model: studies with dexamethasone. Metabolism 30: 914–918
Steiner DF, Ohagi S, Nagamatsu S, Bell GI, Nishi M (1991) Is islet amyloid polypeptide a significant factor in the pathogenesis or pathophysiology of diabetes? Diabetes 40: 305–309
Bennet WM, Beis CS, Ghatei MA, Byfield PGH, Bloom SR (1994) Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia 37: 436–438
Fox N, Schrementi J, Nishi M et al. (1993) Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323: 40–44
Verchere CB, D'Alessio DAD, Palmiter RD, Kahn SE (1994) Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro. Diabetologia 37: 725–728
Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756–760
Young AA, Gedulin B, Gaeta LSL et al. (1994) Selective amylin antagonist suppresses rise in plasma lactate seen after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin. FEBS Lett 343: 237–241
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mulder, H., Ahrén, B., Stridsberg, M. et al. Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment. Diabetologia 38, 395–402 (1995). https://doi.org/10.1007/BF00410276
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00410276